Is the ANA a good screening test for SLE

Is the ANA a good screening test for SLE or another autoimmune disease?

No. Simple mathematics indicates that if 5% of the US population is ANA-positive, then 16 million individuals will have a positive ANA. In contrast, the prevalence of SLE is only approximately 1/1000 (320,000 individuals with SLE in the United States). Thus, even if we presume 100% of SLE patients are ANA-positive, screening the entire population for ANA would result in many more normal individuals detected who are ANA-positive than SLE (i.e., 50 to 1). The clinical value of an ANA test is tremendously enhanced by ordering an ANA when there is a reasonable pre-test probability (i.e., clinical suspicion) of an autoimmune disease. Alternatively, a negative ANA (or 1:40 titer) makes it highly unlikely that the patient has SLE, mixed connective tissue disease (MCTD), Sjögren’s syndrome, or systemic sclerosis (high-sensitivity tests help rule out disease).

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856
Scroll to Top